Fda-compliant DLC coating for improved product evacuation in packaging

Technology
In development
Company

An innovative FDA-compliant diamond-like carbon (DLC) coating that reduces adhesion and wall friction, enabling near-complete evacuation of viscous products from packaging. Compatible with existing manufacturing processes and recyclable materials.

Overview

This solution offers an FDA-compliant diamond-like carbon (DLC) inner-surface coating applied via roll-to-roll plasma deposition on packaging materials. The ultrathin amorphous carbon layer significantly reduces adhesion and wall friction, allowing near-complete evacuation of viscous products like toothpaste and creams. This not only minimizes consumer frustration but also supports sustainability by enhancing recyclability. The DLC coating is chemically inert, transparent, and thermally stable, making it ideal for maintaining seal integrity at high temperatures.

Technical specifications

Key features:

  • Ultrathin Coating: 10-50 nm DLC layer that is invisible and adds negligible weight.
  • Compatibility: Suitable for HDPE mono-material and HDPE+EVOH structures.
  • Thermal Stability: Tolerates sealing temperatures up to ~250 °C.
  • Scalability: Supports high-throughput manufacturing processes.
  • Inertness: Chemically inert and food-contact approved, ensuring product safety.

Applications:

  • Viscous product evacuation from tubes and bottles, such as toothpaste, creams, and gels.
  • Can be integrated into existing packaging lines without altering design or process conditions.
Technology readiness level

This technology is at TRL 6, having been validated in a relevant environment with further optimization and pilot testing planned. The path to commercialization includes further phases focusing on safety, compliance, and scale-up.


About Southwest Research Institute

Southwest Research Institute (SwRI) is an independent, non-profit research organization providing contract research, development, and manufacturing services across biomedical and pharmaceutical development. It supports clients with FDA-inspected CGMP capabilities and expertise spanning process development, analytical and quality control, and scale-up to clinical and manufacturing stages.

Sign up to access the full partnering listing.
View the details of this partnering listing and connect directly with the teams behind promising technologies.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.